Dr. Deepak L. Bhatt
@dlbhattmd.bsky.social
Deepak L. Bhatt, MD, MPH, MBA, FACC, FAHA, FESC, MSCAI, is the Director of the Mount Sinai Fuster Heart Hospital and the Dr. Valentin Fuster Professor of Cardiovascular Medicine (with Tenure) at the Icahn School of Medicine at Mount Sinai in New York City.
Great night at the Mount Sinai Health System Board of Trustees Dinner with my former boss, Dr. Toby Cosgrove, prior CEO of @clevelandclinic.bsky.social, and current boss, Dr. Brendan Carr, CEO of Mount Sinai Health System!
October 13, 2025 at 12:51 PM
Great night at the Mount Sinai Health System Board of Trustees Dinner with my former boss, Dr. Toby Cosgrove, prior CEO of @clevelandclinic.bsky.social, and current boss, Dr. Brendan Carr, CEO of Mount Sinai Health System!
Mount Sinai Fuster Heart Hospital celebration of our #2 national ranking in US News & World Report. #cardiology #cardiovascular
September 18, 2025 at 11:57 AM
Mount Sinai Fuster Heart Hospital celebration of our #2 national ranking in US News & World Report. #cardiology #cardiovascular
Welcome to our new #cardiology fellows at Mount Sinai Hospital!
July 1, 2025 at 6:27 PM
Welcome to our new #cardiology fellows at Mount Sinai Hospital!
Just out in @science.org Translational Medicine - more data supporting the pleiotropic benefits of EPA: Icosapent ethyl reduces arterial thrombosis by inhibition of cyclooxygenase-1–induced platelet reactivity www.science.org/doi/10.1126/... #cardiology #CardioSky #cardiovascular #MedSky #EndoSky
Icosapent ethyl reduces arterial thrombosis by inhibition of cyclooxygenase-1–induced platelet reactivity
Dose-dependent platelet inhibition by icosapent ethyl contributes to beneficial effects of polyunsaturated omega-3 fatty acids.
www.science.org
May 22, 2025 at 7:20 PM
Just out in @science.org Translational Medicine - more data supporting the pleiotropic benefits of EPA: Icosapent ethyl reduces arterial thrombosis by inhibition of cyclooxygenase-1–induced platelet reactivity www.science.org/doi/10.1126/... #cardiology #CardioSky #cardiovascular #MedSky #EndoSky
#cardiology #cardiovascular #MedSky #EndoSky #CardioSky #RenalSky @thelancetendo.bsky.social @thelancet.bsky.social
The ischaemic benefit on both myocardial infarction & stroke has not been previously observed with other SGLT inhibitors & warrants investigation of combined SGLT1/SGLT2 inhibition as a possible underlying mechanism thelancet.com/journals/lan...
#T2D #CVD #CKD
#MedSky #EndoSky #CardioSky #RenalSky
#T2D #CVD #CKD
#MedSky #EndoSky #CardioSky #RenalSky
Effect of sotagliflozin on major adverse cardiovascular events: a prespecified secondary analysis of the SCORED randomised trial
Sotagliflozin reduced MACE, with independent reductions in myocardial infarction and
stroke, among patients with type 2 diabetes, chronic kidney disease, and additional
cardiovascular risk. The ischae...
thelancet.com
May 14, 2025 at 12:33 PM
🚨 Now up
@escardio.bsky.social
Acute coronary syndromes: together w/
@dlbhattmd.bsky.social, C Mueller & P Libby we call for a precision medicine approach
🔹 Diverse mechanisms
🔹 Sex-specific differences
🔹 Shifting risk factor profiles
🔹 AI tools for personalised care
doi.org/10.1093/eurh...
@escardio.bsky.social
Acute coronary syndromes: together w/
@dlbhattmd.bsky.social, C Mueller & P Libby we call for a precision medicine approach
🔹 Diverse mechanisms
🔹 Sex-specific differences
🔹 Shifting risk factor profiles
🔹 AI tools for personalised care
doi.org/10.1093/eurh...
May 14, 2025 at 12:25 PM
NEW: Oxford University's Executive MBA (EMBA) programme from the Said Business School has been ranked as the best in the world by QS for the second consecutive year 🏆
Read more ⬇️
Read more ⬇️
Oxford’s Executive MBA ranked world number one by QS | University of
The University of Oxford’s Executive MBA (EMBA) programme from the Saïd Business School has been ranked as the best in the world by QS for the second consecutive year.
www.ox.ac.uk
April 30, 2025 at 10:08 PM
Potential impact of the ongoing VICTORION-1 PREVENT trial - bottom line, millions of patients could be eligible for therapy with inclisiran. #CardioSky #MedSky #Cardiology #Cardiovascular #Prevention @ajpcardio.bsky.social
>23 million US adults meet criteria for the ongoing trial of inclisiran for primary prevention (VICTORION-1 Prevent), yet rates of lipid-lowering therapy use are low among this high-risk population.
www.sciencedirect.com/science/arti...
#CardioSky #MedSky
www.sciencedirect.com/science/arti...
#CardioSky #MedSky
April 27, 2025 at 4:37 PM
Potential impact of the ongoing VICTORION-1 PREVENT trial - bottom line, millions of patients could be eligible for therapy with inclisiran. #CardioSky #MedSky #Cardiology #Cardiovascular #Prevention @ajpcardio.bsky.social
Wonderful 19th VF Society meeting last night at The New York Academy of Medicine! #cardiology #cardiovascular
April 25, 2025 at 9:34 PM
Wonderful 19th VF Society meeting last night at The New York Academy of Medicine! #cardiology #cardiovascular
Calibration of ECG-Based Deep-Learning Algorithm Scores for Patients Flagged as High Risk for Hypertrophic Cardiomyopathy | NEJM AI ai.nejm.org/doi/full/10.... #cardiology #AI
Calibration of ECG-Based Deep-Learning Algorithm Scores for Patients Flagged as High Risk for Hypertrophic Cardiomyopathy
Despite optimism for the incorporation of deep-learning (DL) algorithms into clinical practice, there is a lack of prospective data on how U.S. Food and Drug Administration (FDA)–cleared algorithms...
ai.nejm.org
April 24, 2025 at 4:40 PM
Calibration of ECG-Based Deep-Learning Algorithm Scores for Patients Flagged as High Risk for Hypertrophic Cardiomyopathy | NEJM AI ai.nejm.org/doi/full/10.... #cardiology #AI
Key Insights for Thromboembolic Disease Prevention, now available online at ms.spr.ly/6012W7yq8 #cardiology #cardiovascular #CME @medscape.com @medscape.org
AHA Conference Recap: Key Insights for Thromboembolic Disease Prevention
Enjoy the videos and music you love, upload original content, and share it all with friends, family, and the world on YouTube.
ms.spr.ly
April 23, 2025 at 1:50 PM
Key Insights for Thromboembolic Disease Prevention, now available online at ms.spr.ly/6012W7yq8 #cardiology #cardiovascular #CME @medscape.com @medscape.org